Expert Interview
A second look: Discussing new therapies in development including tebipenem pivoxil hydrobromide (tebipenem HBr), an oral carbapenem antibiotic currently in development by GSK & Spero to potentially treat complicated urinary tract infections
Ticker(s): GSK, SPRO- Board-certified by the American Board of Urology.
- Named one of regions Top Urologists and featured in Hudson Valley Magazine and recognized by Castle Connolly as a Top Doctor since 2018
- Particular focus in endourology and Men’s Health; and has significant experience and interest in the treatment of kidney stones, cancers of the bladder and prostate, prostate obstruction, incontinence, voiding dysfunction, peyronie’s disease, erectile dysfunction, infertility, and hormonal imbalances, including low testosterone therapy.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
